These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19151751)

  • 1. p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities.
    Yang XY; Guan M; Vigil D; Der CJ; Lowy DR; Popescu NC
    Oncogene; 2009 Mar; 28(11):1401-9. PubMed ID: 19151751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional cross-talk between ras and rho pathways: a Ras-specific GTPase-activating protein (p120RasGAP) competitively inhibits the RhoGAP activity of deleted in liver cancer (DLC) tumor suppressor by masking the catalytic arginine finger.
    Jaiswal M; Dvorsky R; Amin E; Risse SL; Fansa EK; Zhang SC; Taha MS; Gauhar AR; Nakhaei-Rad S; Kordes C; Koessmeier KT; Cirstea IC; Olayioye MA; Häussinger D; Ahmadian MR
    J Biol Chem; 2014 Mar; 289(10):6839-6849. PubMed ID: 24443565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SH3 domain regulation of RhoGAP activity: Crosstalk between p120RasGAP and DLC1 RhoGAP.
    Chau JE; Vish KJ; Boggon TJ; Stiegler AL
    Nat Commun; 2022 Aug; 13(1):4788. PubMed ID: 35970859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA.
    Joshi R; Qin L; Cao X; Zhong S; Voss C; Min W; Li SSC
    J Biol Chem; 2020 Jan; 295(2):645-656. PubMed ID: 31806702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation.
    Cao X; Voss C; Zhao B; Kaneko T; Li SS
    Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1455-60. PubMed ID: 22307599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-Associated Point Mutations in the
    Wang D; Qian X; Sanchez-Solana B; Tripathi BK; Durkin ME; Lowy DR
    Cancer Res; 2020 Sep; 80(17):3568-3579. PubMed ID: 32606003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK).
    Li G; Du X; Vass WC; Papageorge AG; Lowy DR; Qian X
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17129-34. PubMed ID: 21969587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities.
    Qian X; Li G; Asmussen HK; Asnaghi L; Vass WC; Braverman R; Yamada KM; Popescu NC; Papageorge AG; Lowy DR
    Proc Natl Acad Sci U S A; 2007 May; 104(21):9012-7. PubMed ID: 17517630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function.
    Chan LK; Ko FC; Ng IO; Yam JW
    PLoS One; 2009; 4(5):e5572. PubMed ID: 19440389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.
    Tripathi BK; Grant T; Qian X; Zhou M; Mertins P; Wang D; Papageorge AG; Tarasov SG; Hunter KW; Carr SA; Lowy DR
    J Cell Biol; 2017 Dec; 216(12):4255-4270. PubMed ID: 29114068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDK5 is a major regulator of the tumor suppressor DLC1.
    Tripathi BK; Qian X; Mertins P; Wang D; Papageorge AG; Carr SA; Lowy DR
    J Cell Biol; 2014 Dec; 207(5):627-42. PubMed ID: 25452387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DLC1 activation requires lipid interaction through a polybasic region preceding the RhoGAP domain.
    Erlmann P; Schmid S; Horenkamp FA; Geyer M; Pomorski TG; Olayioye MA
    Mol Biol Cell; 2009 Oct; 20(20):4400-11. PubMed ID: 19710422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
    Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
    Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor activates the Rho GTPase-activating protein (GAP) Deleted in Liver Cancer 1 via focal adhesion kinase and protein phosphatase 2A.
    Ravi A; Kaushik S; Ravichandran A; Pan CQ; Low BC
    J Biol Chem; 2015 Feb; 290(7):4149-62. PubMed ID: 25525271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma.
    Wong CC; Wong CM; Ko FC; Chan LK; Ching YP; Yam JW; Ng IO
    PLoS One; 2008 Jul; 3(7):e2779. PubMed ID: 18648664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tensin1 positively regulates RhoA activity through its interaction with DLC1.
    Shih YP; Sun P; Wang A; Lo SH
    Biochim Biophys Acta; 2015 Dec; 1853(12):3258-65. PubMed ID: 26427649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1.
    Sanchez-Solana B; Wang D; Qian X; Velayoudame P; Simanshu DK; Acharya JK; Lowy DR
    Mol Cancer; 2021 Nov; 20(1):141. PubMed ID: 34727930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase.
    Hildebrand JD; Taylor JM; Parsons JT
    Mol Cell Biol; 1996 Jun; 16(6):3169-78. PubMed ID: 8649427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathway.
    Ullmannova-Benson V; Guan M; Zhou X; Tripathi V; Yang XY; Zimonjic DB; Popescu NC
    Leukemia; 2009 Feb; 23(2):383-90. PubMed ID: 18923442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SRC and ERK cooperatively phosphorylate DLC1 and attenuate its Rho-GAP and tumor suppressor functions.
    Tripathi BK; Anderman MF; Qian X; Zhou M; Wang D; Papageorge AG; Lowy DR
    J Cell Biol; 2019 Sep; 218(9):3060-3076. PubMed ID: 31308216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.